avrg: GSE58827: Dynamics of the Mouse Liver
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_65101453 Show fit | 8.44 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
immunoglobulin superfamily, DCC subclass, member 4 |
|
chr11_-_96005872 Show fit | 8.26 |
ENSMUST00000013559.2
|
insulin-like growth factor 2 mRNA binding protein 1 |
|
chr10_-_45470201 Show fit | 5.68 |
ENSMUST00000079390.6
|
lin-28 homolog B (C. elegans) |
|
chrX_+_93654863 Show fit | 5.14 |
ENSMUST00000113933.2
|
phosphate cytidylyltransferase 1, choline, beta isoform |
|
chr4_-_134018829 Show fit | 4.16 |
ENSMUST00000051674.2
|
lin-28 homolog A (C. elegans) |
|
chr6_-_49214954 Show fit | 4.09 |
ENSMUST00000031838.7
|
insulin-like growth factor 2 mRNA binding protein 3 |
|
chr2_-_152415044 Show fit | 3.96 |
ENSMUST00000099207.3
|
zinc finger, CCHC domain containing 3 |
|
chr1_+_86303221 Show fit | 3.50 |
ENSMUST00000113306.2
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
|
chr6_-_52226165 Show fit | 3.24 |
ENSMUST00000114425.2
|
homeobox A9 |
|
chr11_+_44617310 Show fit | 2.99 |
ENSMUST00000081265.5
ENSMUST00000101326.3 ENSMUST00000109268.1 |
early B cell factor 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 9.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.7 | 8.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 5.2 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 5.1 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 4.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 3.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 2.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 2.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.3 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 2.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 4.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.8 | 2.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 2.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 2.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 12.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.0 | 5.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 4.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 4.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 3.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.9 | 2.7 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.0 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 2.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 8.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 2.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 5.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 3.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 3.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |